The CiticOline Brain Injury Trial (COBRIT) has enrolled 1,213 patients with mild-to-severe TBI and assessed the effect of enteral or oral citicoline (2,000 mg/day, for 90 days) on functional and cognitive outcomes (measured by components of the TBI Clinical Trials Network Care Battery) (103)
How the MindBody GLP-1 System Works Its Magic The MindBody GLP-1 System takes this natural process and supercharges it
doi 10.1111/1440-1681.13361 89 JeppesenPGilroyRPertkiewiczMAllardJMessingBO'KeefeS
Tirzepatide (dual GIP and GLP-1 agonist) 4
A., Zangani, M., Haraldsen, G., Bogen, B., & Corthay, A